Results 151 to 160 of about 123,621 (353)

UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Epilepsy

Brain and Behavior
Background A third of epilepsy patients fail to enter seizure remission despite optimal therapeutic management. Cannabis‐based medicinal products (CBMPs) have shown promise as a potential therapy.
Isaac Cowley, Simon Erridge, Arushika Aggarwal, Lilia Evans, Madhur Varadpande, Evonne Clarke, Katy McLachlan, Ross Coomber, Augustin Iqbal, James J Rucker, Mark W Weatherall, Mikael H Sodergren   +11 more
doaj   +1 more source

Commentary on Borodovsky et al.: Enhancing research on THC quantification—Consumer awareness through accurate labelling

Addiction, Volume 120, Issue 4, Page 686-687, April 2025.
Rachel Lees Thorne, Tom P. Freeman
wiley   +1 more source

Trends in fentanyl‐containing drug samples seized by law enforcement agencies across Canada

Addiction, EarlyView.
Abstract Background and aims Canada's drug toxicity crisis has been largely attributed to a volatile fentanyl‐dominated unregulated drug supply with increasing reports of fentanyl detected in combination with benzodiazepines, stimulants and xylazine.
Shaleesa Ledlie, Ria Garg, Pamela Leece, Gillian Kolla, Elaine Hyshka, Mina Tadrous, Tara Gomes   +6 more
wiley   +1 more source

Medical Marijuana in Arkansas: The Risks of Rushed Drafting [PDF]

, 2019
Arkansas voters passed the Arkansas Medical Marijuana Amendment to the state constitution in late 2016. Almost certainly, the vast majority of voters did so without reading or understanding the intricacies of the initiative, and instead voted simply to ...
Goforth, Carol, Goforth, Robyn
core   +2 more sources

Hippocampal subfield differences in people with and without recreational ketamine use: Insights from multi‐modal neuroimaging

Addiction, EarlyView.
Abstract Background and aims Recreational ketamine use has increased globally and is associated with psychiatric and cognitive concerns. The hippocampus in preclinical models shows damage and working‐memory disruption with repeated dosing. However, whether specific hippocampal subregions may differ in people with chronic ketamine use remains unclear ...
Yi‐Hsuan Liu, Chia‐Chun Hung, Marc N. Potenza, Kun‐Hsien Chou, Pei‐Lin Lee, Chu‐Chung Huang, Chiang‐Shan R. Li, Tony Szu‐Hsien Lee, Ching‐Po Lin   +8 more
wiley   +1 more source

Cannabis use in a Canadian long-term care facility: a case study

BMC Geriatrics
Background Following the legalization of cannabis in Canada in 2018, people aged 65 + years reported a significant increase in cannabis consumption.
Lynda G. Balneaves, Abeer A. Alraja, Genevieve Thompson, Jamie L. Penner, Philip St. John, Daniella Scerbo, Joanne van Dyck   +6 more
doaj   +1 more source

Medical Cannabis Bank on the Tamka Island in Wrocław

, 2017
E. Komendacka, Paweł Kirschke
openalex   +1 more source

Sex differences in driving under the influence of cannabis: The role of medical and recreational cannabis use

, 2020
Shawnta L. Lloyd, Catalina Lopez‐Quintero, Catherine W. Striley   +2 more
openalex   +2 more sources

Adolescent cannabis use and psychological distress from 2013 to 2023: A population‐based study in Ontario, Canada

Addiction, EarlyView.
Abstract Background and aims Epidemiologic research suggests that adolescent cannabis use is associated with psychological distress (i.e. depression and anxiety symptoms); however, most studies have relied on 20th‐century data, when cannabis was significantly less potent than today.
André J. McDonald, Amanda Doggett, Susan J. Bondy, Ian Colman, Steven Cook, Hayley A. Hamilton, Paul Kurdyak, Scott T. Leatherdale, Daniel T. Myran, Jürgen Rehm, Christine M. Wickens, James MacKillop, Jillian Halladay   +12 more
wiley   +1 more source

Knowledge and attitudes of health professionals towards medical Cannabis in Brazil [PDF]

Carlos Alberto Fernandes Salvo, Ana Carolina Rennó Sodero, Mário Gandra   +2 more
openalex   +1 more source